Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Diethylentriaminepenta acetic acid glucose conjugates as a cell permeable iron chelator
Mona Mosayebnia1, Mehdi Shafiee-Ardestani2, Parvin Pasalar3
1Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Objective:
To find out whether DTPA-DG complex can enhance clearance of intracellular free iron.
Materials And Methods:
Diethylenetriaminepentaacetic acid-D-deoxy-glucosamine (DTPA-DG) was synthesized and examined for its activity as a cell-permeable iron chelator in human hepatocellular carcinoma (HEPG2) cell line exposed to high concentration of iron sulfate and compared with deferoxamine (DFO), a prototype iron chelator. The effect of DTPA-DG on cell viability was monitored using the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide MTT assay as well.
Results:
There was a significant increase of iron level after iron overload induction in HEPG2 cell culture. DTPA-DG presented a remarkable capacity to iron burden reducing with estimated 50% inhibitory concentration value of 65.77 nM. In fact, glycosyl moiety was gained access of DTPA to intracellular iron deposits through glucose transporter systems.
Conclusion:
DTPA-DG, more potent than DFO to sequester deposits of free iron with no profound toxic effect. The results suggest the potential of DTPA-DG in chelating iron and permitting its excretion from primary organ storage.
Related Concept Videos
EDTA: Chemistry and Properties
Complexation Equilibria: The Chelate Effect
The Early Endosome: Endocytosis of Transferrin
EDTA: Auxiliary Complexing Reagents

